These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34157805)

  • 1. Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors - dutasteride and finasteride - in the presence of testosterone.
    Hatanaka T; Lulic Z; Mefo T; Booth C; Harrison E; Ong G
    Singapore Med J; 2022 Sep; 63(9):552-558. PubMed ID: 34157805
    [No Abstract]   [Full Text] [Related]  

  • 2. Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results.
    Traish AM; Krakowsky Y; Doros G; Morgentaler A
    Sex Med Rev; 2019 Jan; 7(1):95-114. PubMed ID: 30098986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer cells differ in testosterone accumulation, dihydrotestosterone conversion, and androgen receptor signaling response to steroid 5α-reductase inhibitors.
    Wu Y; Godoy A; Azzouni F; Wilton JH; Ip C; Mohler JL
    Prostate; 2013 Sep; 73(13):1470-82. PubMed ID: 23813697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Oral 5-alpha Reductase Inhibitors on Penile Intracavernosal Pressures and Penile Morphology in Rat Model.
    Kilic S; Kolukcu E; Erdemir F; Benli I; Arici A
    Urol J; 2019 May; 16(2):205-211. PubMed ID: 30058066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model.
    Da Silva MHA; Costa WS; B Sampaio FJ; De Souza DB
    Asian J Androl; 2018; 20(5):505-510. PubMed ID: 29893293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss.
    Wang ZD; Feng Y; Ma LY; Li X; Ding WF; Chen XM
    Biomed Pharmacother; 2017 May; 89():438-446. PubMed ID: 28249244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus.
    Ushirobira CY; Afiune LAF; Pereira MN; Cunha-Filho M; Gelfuso GM; Gratieri T
    Int J Biol Macromol; 2020 May; 151():56-61. PubMed ID: 32068053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles.
    Hoffmann R; Happle R
    Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of 5alpha-reductase inhibition with finasteride and dutasteride on bone mineral density in older men with benign prostatic hyperplasia.
    Mačukat IR; Spanjol J; Orlič ZC; Butorac MZ; Marinovič M; Ćupič DF
    Coll Antropol; 2014 Sep; 38(3):835-9. PubMed ID: 25420363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man.
    Hazlehurst JM; Oprescu AI; Nikolaou N; Di Guida R; Grinbergs AE; Davies NP; Flintham RB; Armstrong MJ; Taylor AE; Hughes BA; Yu J; Hodson L; Dunn WB; Tomlinson JW
    J Clin Endocrinol Metab; 2016 Jan; 101(1):103-13. PubMed ID: 26574953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific.
    Chhipa RR; Halim D; Cheng J; Zhang HY; Mohler JL; Ip C; Wu Y
    Prostate; 2013 Oct; 73(14):1483-94. PubMed ID: 23813737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5α-reductase type 1 modulates insulin sensitivity in men.
    Upreti R; Hughes KA; Livingstone DE; Gray CD; Minns FC; Macfarlane DP; Marshall I; Stewart LH; Walker BR; Andrew R
    J Clin Endocrinol Metab; 2014 Aug; 99(8):E1397-406. PubMed ID: 24823464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study.
    Memar Bashi Aval M; Hoveizi E; Mombeiny R; Kazemi M; Saeedi S; Tavakol S
    IET Nanobiotechnol; 2023 Feb; 17(1):13-21. PubMed ID: 36314605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
    Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride.
    Byrns MC; Mindnich R; Duan L; Penning TM
    J Steroid Biochem Mol Biol; 2012 May; 130(1-2):7-15. PubMed ID: 22265960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.